SpO2 area of the 6 minute-walk test

SpO2 area of the 6 minute-walk test - SpO2 area of the 6 minute-walk test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016511

Enrollment

Registered

2015-02-16

Start date

2015-02-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic pulmonary fibrosis Chronic Obstructive Pulmonary Disesase Combined Pulmonary Fibrosis and Emphysema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. FVC>1.0L in IPF/CPFE patients 2. 30%<=%FEV1<80% in COPD patients 3. all patients provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. patients who received therapy of the lung cancer. 2. patient who have treatment with the home oxygen therapy. 3. patients who had a history of the angina pectoralis within 1 month. 4. patient who have walking disturbance. 5. considered ineligible for the study by the investigator.

Design outcomes

Primary

Measure	Time frame
Change in SpO2 area	—

Secondary

Measure	Time frame
1.Change in 6 minute-walk distance. 2.Changes in pulmonary function test(VC, FVC, FEV1, FEV1/FVC, DLco, DLco/VA, R5, R20, R5-R20, X5, Fres, ALX).	—

Countries

Japan

Contacts

Public ContactAkito Yamamoto

Shizuoka General Hospital Respiratory medicine

akito-yamamoto@i.shizuoka-pho.jp054-247-6111

Outcome results